Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models

• Glen M. Boyle ,

  Contributed equally to this work with: Glen M. Boyle, Marjorie M. A. D'Souza

  * E-mail: Glen.Boyle@qimrberghofer.edu.au

  Affiliation Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

  ⨯
• Marjorie M. A. D'Souza ,

  Contributed equally to this work with: Glen M. Boyle, Marjorie M. A. D'Souza

  Affiliations Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia, School of Medicine, University of Queensland, Brisbane, Queensland, Australia

  ⨯
• Carly J. Pierce,

  Affiliation Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

  ⨯
• Ryan A. Adams,

  Affiliations Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia, School of Medicine, University of Queensland, Brisbane, Queensland, Australia, Department of Otolaryngology, Head and Neck Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia

  ⨯
• Aaron S. Cantor,

  Affiliation Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

  ⨯
• Jenny P. Johns,

  Affiliation Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

  ⨯
• Lidia Maslovskaya,

  Affiliation Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

  ⨯
• Victoria A. Gordon,

  Affiliation QBiotics Ltd., Yungaburra, Queensland, Australia

  ⨯
• Paul W. Reddell,

  Affiliation QBiotics Ltd., Yungaburra, Queensland, Australia

  ⨯
• Peter G. Parsons

  Affiliation Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

  ⨯